4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-22-000020
Chief Medical Officer sold 2,021 shares at an average $15.11 ($30,531)
- Chief Medical Officer acquired 2,021 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KREHER NERISSA Chief Medical Officer | 2022-09-08 | Option exercise | +1,221 | $2.10 | $2,564 | 21,937 | D |
| KREHER NERISSA Chief Medical Officer | 2022-09-08 | Sale | −1,221 | $15.13 | $18,478 | 20,716 | D |
| KREHER NERISSA Chief Medical Officer | 2022-09-09 | Option exercise | +800 | $2.10 | $1,680 | 21,516 | D |
| KREHER NERISSA Chief Medical Officer | 2022-09-09 | Sale | −800 | $15.07 | $12,054 | 20,716 | D |
| Derivatives | |||||||
| KREHER NERISSA Chief Medical Officer | 2022-09-08 | Option exercise · Stock Option (Right to Buy) | −1,221 | 29,811 | D | ||
| KREHER NERISSA Chief Medical Officer | 2022-09-09 | Option exercise · Stock Option (Right to Buy) | −800 | 29,011 | D | ||
| Open-market sales · 2,021 sh · avg $15.11 · $30,531 | |||||||
Loading xslF345X03/wf-form4_166301390290805.xml…